Huang-Tz Ou

2024

Adaptation of risk prediction equations for cardiovascular outcomes among patients with type 2 diabetes in real-world settings: a cross-institutional study using common data model approach

Yang, C. T., Chong, K. S., Wang, C. C., Ou, H. T. & Kuo, S., 2024 12月, 於: Cardiovascular Diabetology. 23, 1, 244.

研究成果: Article › 同行評審

開啟存取

Kidney outcomes with SGLT2is for type 2 diabetes patients: does background treatment with metformin or RASis matter?

Chong, K. S., Chang, Y. H., Lin, M. H., Hsu, C. N., Wang, C. C., Wang, C. Y., Huang, Y. L., Lin, F. J. & Ou, H. T., 2024, 於: Frontiers in Endocrinology. 15, 1329945.

研究成果: Article › 同行評審

開啟存取

Longitudinal economic burden of incident complications among metabolic syndrome populations

Chong, K. S., Chang, Y. H., Yang, C. T., Chou, C. K., Ou, HT. & Kuo, S., 2024 12月, 於: Cardiovascular Diabetology. 23, 1, 246.

研究成果: Article › 同行評審

開啟存取

Long-Term Sulfonylurea Use and Impaired Awareness of Hypoglycemia Among Patients With Type 2 Diabetes in Taiwan

Cheng, H. J., Weng, S. H., Wu, J. L., Yeh, S. T., Chen, H. F., Novida, H., Ou, H-T. & Li, C. Y., 2024 7月 1, 於: Annals of Family Medicine. 22, 4, p. 309-316 8 p.

研究成果: Article › 同行評審

開啟存取

Lower risks of cirrhosis and hepatocellular carcinoma with GLP-1RAs in type 2 diabetes: A nationwide cohort study using target trial emulation framework

Yang, C. T., Yao, W. Y., Yang, C. Y., Peng, Z. Y., Ou, H. T. & Kuo, S., 2024 3月, 於: Journal of Internal Medicine. 295, 3, p. 357-368 12 p.

研究成果: Article › 同行評審

7 引文斯高帕斯（Scopus）

Robust inference for causal mediation analysis of recurrent event data

Chen, Y. L., Chen, Y. H., Su, P. F., Ou, H. T. & Tai, A. S., 2024 7月 20, 於: Statistics in Medicine. 43, 16, p. 3020-3035 16 p.

研究成果: Article › 同行評審

開啟存取

2023

Chronic kidney outcomes associated with GLP-1 receptor agonists versus long-acting insulins among type 2 diabetes patients requiring intensive glycemic control: a nationwide cohort study

Peng, Z. Y., Yang, C. T., Lin, W. H., Yao, W. Y., Ou, H. T. & Kuo, S., 2023 12月, 於: Cardiovascular Diabetology. 22, 1, 272.

研究成果: Article › 同行評審

開啟存取

9 引文斯高帕斯（Scopus）

Cost-effectiveness of first-line immunotherapies for advanced non-small cell lung cancer

Yang, S. C., Ou, H. T., Su, W. C. & Wang, S. Y., 2023 4月, 於: Cancer medicine. 12, 7, p. 8838-8850 13 p.

研究成果: Article › 同行評審

開啟存取

6 引文斯高帕斯（Scopus）

Cost-effectiveness of Novel Macrophage-Regulating Treatment for Wound Healing in Patients with Diabetic Foot Ulcers from the Taiwan Health Care Sector Perspective

Su, H. Y., Yang, C. Y., Ou, H. T., Chen, S. G., Chen, J. C., Ho, H. J. & Kuo, S., 2023 1月 12, 於: JAMA network open. 6, 1, p. E2250639

研究成果: Article › 同行評審

開啟存取

6 引文斯高帕斯（Scopus）

Effect of atosiban on in vitro fertilization pregnancy outcome among women with endometriosis in presence or absence of adenomyosis

Lin, C. W., Wu, M. H., Mau, Y. L., Su, P. F. & Ou, H. T., 2023 7月, 於: Taiwanese Journal of Obstetrics and Gynecology. 62, 4, p. 537-542 6 p.

研究成果: Article › 同行評審

開啟存取

3 引文斯高帕斯（Scopus）

Effect of SGLT2 inhibitors versus DPP4 inhibitors on major and non-major osteoporotic fracture risks among general and high-risk type 2 diabetes patients: A nationwide retrospective cohort study

Peng, Z. Y., Wang, Y. T., Chang, C. S., Wu, C. H. & Ou, H. T., 2023 9月, 於: Diabetes and Metabolism. 49, 5, 101465.

研究成果: Article › 同行評審

2 引文斯高帕斯（Scopus）

Efficient estimation of a Cox model when integrating the subgroup incidence rate information

Su, P. F., Zhong, J., Liu, Y. C., Lin, T. H. & Ou, H. T., 2023, 於: Journal of Applied Statistics. 50, 10, p. 2151-2170 20 p.

研究成果: Article › 同行評審

Factors predictive of clinical outcome in advanced hepatocellular carcinoma patients receiving ramucirumab treatment: A real-world experience

Lin, P. T., Hung, M. H., Shao, S. C., Chen, H. Y., Chan, Y. Y., Chang, K. C., Lin, S. M. & Ou, H. T., 2023 7月, 於: Cancer medicine. 12, 14, p. 14902-14911 10 p.

研究成果: Article › 同行評審

開啟存取

Herpes zoster associated with stroke incidence in people living with human immunodeficiency virus: a nested case–control study

Ku, H. C., Wu, Y. L., Yip, H. T., Hsieh, C. Y., Li, C. Y., Ou, H. T., Chen, Y. C. & Ko, N. Y., 2023 12月, 於: BMC infectious diseases. 23, 1, 636.

研究成果: Article › 同行評審

開啟存取

4 引文斯高帕斯（Scopus）

Real-life analysis of neoadjuvant-therapy-associated benefits for pathological complete response and survival in early breast cancer patients - role of trastuzumab in HER2+ BC and platinum in TNBC

Chung, W. P., Yang, C. T., Yang, S. R., Su, C. Y., Su, H. W., Liu, S. Y. & Ou, H. T., 2023 1月 24, 於: Frontiers in Oncology. 12, 1022994.

研究成果: Article › 同行評審

開啟存取

Value of GLP-1 receptor agonists versus long-acting insulins for type 2 diabetes patients with and without established cardiovascular or chronic kidney diseases: A model-based cost-effectiveness analysis using real-world data

Yang, C. T., Yao, W. Y., Ou, H. T. & Kuo, S., 2023 4月, 於: Diabetes Research and Clinical Practice. 198, 110625.

研究成果: Article › 同行評審

4 引文斯高帕斯（Scopus）

2022

Association of retinopathy severity with cardiovascular and renal outcomes in patients with type 1 diabetes: a multi-state modeling analysis

Wang, W. M., Ou, H. T., Wen, M. J., Su, P. F., Yang, C. Y., Kuo, T. H., Wang, M. C. & Lin, W. H., 2022 12月, 於: Scientific reports. 12, 1, 4177.

研究成果: Article › 同行評審

開啟存取

4 引文斯高帕斯（Scopus）

Cardiovascular Benefits With Favorable Renal, Amputation and Hypoglycemic Outcomes of SGLT-2 Inhibitors in Type 2 Diabetes From the Asian Perspective: A Population-Based Cohort Study and Systematic Review

Yang, C. T., Peng, Z. Y., Chen, Y. C., Ou, H. T. & Kuo, S., 2022 3月 7, 於: Frontiers in Endocrinology. 13, 836365.

研究成果: Article › 同行評審

開啟存取

15 引文斯高帕斯（Scopus）

Co-Administration of Clomiphene Citrate and Letrozole in Mild Ovarian Stimulation Versus Conventional Controlled Ovarian Stimulation Among POSEIDON Group 4 Patients

Lin, H. T., Wu, M. H., Tsai, L. C., Chen, T. S. & Ou, H. T., 2022 1月 14, 於: Frontiers in Endocrinology. 12, 780392.

研究成果: Article › 同行評審

開啟存取

7 引文斯高帕斯（Scopus）

Continuity and Completeness of Electronic Health Record Data for Patients Treated With Oral Hypoglycemic Agents: Findings From Healthcare Delivery Systems in Taiwan

Hsu, C. N., Huang, K., Lin, F. J., Ou, H. T., Huang, L. Y., Kuo, H. C., Wang, C. C. & Toh, S., 2022 4月 4, 於: Frontiers in Pharmacology. 13, 845949.

研究成果: Article › 同行評審

開啟存取

6 引文斯高帕斯（Scopus）

Cost-effectiveness of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors among patients with type 2 diabetes with and without established cardiovascular diseases: A model-based simulation analysis using 10-year real-world data and targeted literature review

Peng, Z. Y., Yang, C. T., Ou, H. T. & Kuo, S., 2022 7月, 於: Diabetes, Obesity and Metabolism. 24, 7, p. 1328-1337 10 p.

研究成果: Article › 同行評審

6 引文斯高帕斯（Scopus）

Incorporating sperm DNA fragmentation index with computer-assisted semen morphokinematic parameters as a better window to male fertility

Lin, H. T., Wu, M. H., Wu, W. L., Tsai, L. C., Chen, Y. Y., Hung, K. H., Wu, P. H., Chen, T. S., Ou, H. T. & Cheng, Y. S., 2022 5月 1, 於: Chinese Journal of Physiology. 65, 3, p. 143-150 8 p.

研究成果: Article › 同行評審

開啟存取

7 引文斯高帕斯（Scopus）

Restricted Mean Survival Time Analysis to Estimate SGLT2i-Associated Heterogeneous Treatment Effects on Primary and Secondary Prevention of Cardiorenal Outcomes in Patients with Type 2 Diabetes in Taiwan

Peng, Z. Y., Yang, C. T., Kuo, S., Wu, C. H., Lin, W. H. & Ou, H. T., 2022 12月 15, 於: JAMA network open. 5, 12, p. E2246928

研究成果: Article › 同行評審

開啟存取

8 引文斯高帕斯（Scopus）

Three-step matching algorithm to enhance between-group comparability and minimize confounding in comparative effectiveness studies

Yang, C. Y., Kuo, S., Lai, E. C. C. & Ou, H. T., 2022 12月, 於: Scientific reports. 12, 1, 214.

研究成果: Article › 同行評審

開啟存取

3 引文斯高帕斯（Scopus）

Treatment-associated survival outcomes in real-world patients with de novo metastatic triple-negative breast cancer: Age as a significant treatment effect-modifier

Chung, W. P., Yang, C. T., Chen, H. Y., Su, C. Y., Su, H. W. & Ou, H. T., 2022 1月, 於: Journal of the Formosan Medical Association. 121, 1, p. 319-328 10 p.

研究成果: Article › 同行評審

開啟存取

3 引文斯高帕斯（Scopus）

2021

A nationwide cohort study for comparative vascular safety of long-acting insulin analogue versus intermediate-acting human insulin in type 2 diabetes

Yang, C. T., Li, K. Y., Yang, C. Y., Ou, H. T. & Kuo, S., 2021 12月, 於: Scientific reports. 11, 1, 4152.

研究成果: Article › 同行評審

開啟存取

3 引文斯高帕斯（Scopus）

Association of adherence to antiretroviral therapy with economic burden of cardiovascular disease in HIV-infected population

Liao, C. T., Yang, C. T., Chen, P. H., Toh, H. S., Kuo, S., Chen, Z. C., Ou, H. T., Ko, N. Y. & Wang, J. D., 2021 3月 1, 於: European Journal of Preventive Cardiology. 28, 3, p. 326-334 9 p.

研究成果: Article › 同行評審

6 引文斯高帕斯（Scopus）

Association of Renal and Cardiovascular Safety With DPP-4 Inhibitors vs. Sulfonylureas in Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease

Yang, C. T., Lin, W. H., Li, L. J., Ou, H. T. & Kuo, S., 2021 8月, 於: Clinical Pharmacology and Therapeutics. 110, 2, p. 464-472 9 p.

研究成果: Article › 同行評審

3 引文斯高帕斯（Scopus）

Building an active medical product safety surveillance system in Taiwan: Adaptation of the U.S. Sentinel System common data model structure to the National Health Insurance Research Database in Taiwan

Huang, K., Lin, F. J., Ou, H. T., Hsu, C. N., Huang, L. Y., Wang, C. C. & Toh, S., 2021 1月, 於: Pharmacoepidemiology and drug safety. 30, 1, p. 97-101 5 p.

研究成果: Article › 同行評審

13 引文斯高帕斯（Scopus）

Cost-effectiveness evaluation of add-on dapagliflozin for heart failure with reduced ejection fraction from perspective of healthcare systems in Asia–Pacific region

Liao, C. T., Yang, C. T., Toh, H. S., Chang, W. T., Chang, H. Y., Kuo, F. H., Lee, M. C., Hua, Y. M., Tang, H. J., Strong, C. & Ou, H. T., 2021 12月, 於: Cardiovascular Diabetology. 20, 1, 204.

研究成果: Article › 同行評審

開啟存取

16 引文斯高帕斯（Scopus）

Cost-Effectiveness Evaluation of Add-on Empagliflozin in Patients With Heart Failure and a Reduced Ejection Fraction From the Healthcare System's Perspective in the Asia-Pacific Region

Liao, C. T., Yang, C. T., Kuo, F. H., Lee, M. C., Chang, W. T., Tang, H. J., Hua, Y. M., Chang, H. Y., Chen, Z. C., Strong, C., Ou, H-T. & Toh, H. S., 2021, 於: Frontiers in Cardiovascular Medicine. 8, 750381.

研究成果: Article › 同行評審

開啟存取

31 引文斯高帕斯（Scopus）

Cost-effectiveness of GLP-1 receptor agonists versus insulin for the treatment of type 2 diabetes: a real-world study and systematic review

Yang, C. Y., Chen, Y. R., Ou, H. T. & Kuo, S., 2021 12月, 於: Cardiovascular Diabetology. 20, 1, 21.

研究成果: Article › 同行評審

開啟存取

21 引文斯高帕斯（Scopus）

Cost-Effectiveness of Juluca (dolutegravir/rilpivirine) for Human Immunodeficiency Virus (HIV-1) Infection Treatment in Virologically Suppressed Adults in Taiwan

Anderson, S. J., Hsu, C. Y., Ou, H. T., Ko, N. Y., Yang, C. T. & Lopes, S., 2021 5月, 於: Value in Health Regional Issues. 24, p. 216-223 8 p.

研究成果: Article › 同行評審

開啟存取

3 引文斯高帕斯（Scopus）

Hepatic and cardiovascular safety of acarbose among type 2 diabetes patients with end-stage renal disease: A nationwide population-based longitudinal study

Lin, W. H., Yang, C. Y., Kuo, S., Kuo, T. H., Roan, J. N., Li, C. Y., Wang, M. C. & Ou, H. T., 2021 2月, 於: Diabetes Research and Clinical Practice. 172, 108489.

研究成果: Article › 同行評審

5 引文斯高帕斯（Scopus）

Heterogeneous Treatment Effects on Cardiovascular Diseases With Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas in Type 2 Diabetes Patients

Yang, C. Y., Lin, W. A., Su, P. F., Li, L. J., Yang, C. T., Ou, H. T. & Kuo, S., 2021 3月, 於: Clinical Pharmacology and Therapeutics. 109, 3, p. 772-781 10 p.

研究成果: Article › 同行評審

開啟存取

3 引文斯高帕斯（Scopus）

Long-term neurological and healthcare burden of adults with japanese encephalitis: A nationwide study 2000-2015

Chen, H. Y., Yang, C. Y., Hsieh, C. Y., Yeh, C. Y., Chen, C. C., Chen, Y. C., Lai, C. C., Harris, R. C., Ou, H. T., Ko, N. Y. & Ko, W. C., 2021 9月, 於: PLoS neglected tropical diseases. 15, 9, e0009703.

研究成果: Article › 同行評審

開啟存取

11 引文斯高帕斯（Scopus）

Quality of life among infertile women with endometriosis undergoing IVF treatment and their pregnancy outcomes

Wu, M. H., Su, P. F., Chu, W. Y., Lin, C. W., Huey, N. G., Lin, C. Y. & Ou, H. T., 2021, 於: Journal of Psychosomatic Obstetrics and Gynaecology. 42, 1, p. 57-66 10 p.

研究成果: Article › 同行評審

11 引文斯高帕斯（Scopus）

Quality of life with pregnancy outcomes: Further evaluating item properties for refined Taiwan's FertiQoL

Wu, M. H., Chong, K. S., Huey, N. G., Ou, H. T. & Lin, C. Y., 2021 3月, 於: Journal of the Formosan Medical Association. 120, 3, p. 939-946 8 p.

研究成果: Article › 同行評審

開啟存取

4 引文斯高帕斯（Scopus）

Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan

Johnson, B., Lai, E. C. C., Ou, H. T., Li, H. & Stollenwerk, B., 2021 12月, 於: Archives of Osteoporosis. 16, 1, 155.

研究成果: Article › 同行評審

開啟存取

6 引文斯高帕斯（Scopus）

Renoprotective effect of SGLT-2 inhibitors among type 2 diabetes patients with different baseline kidney function: a multi-center study

Lin, F. J., Wang, C. C., Hsu, C. N., Yang, C. Y., Wang, C. Y. & Ou, H. T., 2021 12月, 於: Cardiovascular Diabetology. 20, 1, 203.

研究成果: Article › 同行評審

開啟存取

16 引文斯高帕斯（Scopus）

Valuing health states of people with type 2 diabetes: Analyses of the nationwide representative linked databases

Kuo, S., Yang, C. T., Chen, H. Y. & Ou, H. T., 2021 9月, 於: Journal of Diabetes Investigation. 12, 9, p. 1749-1758 10 p.

研究成果: Article › 同行評審

開啟存取

9 引文斯高帕斯（Scopus）

2020

Association of ambient air pollution with cardiovascular disease risks in people with type 2 diabetes: a Bayesian spatial survival analysis

Su, P. F., Sie, F. C., Yang, C. T., Mau, Y. L., Kuo, S. & Ou, H. T., 2020 12月 1, 於: Environmental Health: A Global Access Science Source. 19, 1, 110.

研究成果: Article › 同行評審

開啟存取

10 引文斯高帕斯（Scopus）

Atosiban and Pregnancy Outcomes Following In Vitro Fertilization Treatment for Infertile Women Requiring One, Two, or More Embryo Transfer Cycles: A Longitudinal Cohort Study

Wu, M. H., Lin, C. W., Su, P. F., Lai, E. C. C., Sie, F. C., Mau, Y. L., Huey, N. G. & Ou, H. T., 2020 3月 1, 於: Reproductive Sciences. 27, 3, p. 853-859 7 p.

研究成果: Article › 同行評審

8 引文斯高帕斯（Scopus）

Community Pharmacists in Taiwan at the Frontline Against the Novel Coronavirus Pandemic: Gatekeepers for the Rationing of Personal Protective Equipment

Ou, H. & Yang, Y. K., 2020 7月 21, 於: Annals of Internal Medicine. 173, 2, p. 149-150

研究成果: Article › 同行評審

Comparative cardiovascular safety of GLP-1 receptor agonists versus other glucose-lowering agents in real-world patients with type 2 diabetes: A nationwide population-based cohort study

Yang, C. T., Yang, C. Y., Ou, H. T. & Kuo, S., 2020 6月 13, 於: Cardiovascular Diabetology. 19, 1, 83.

研究成果: Article › 同行評審

開啟存取

26 引文斯高帕斯（Scopus）

Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: A multi-institutional cohort study and meta-analysis

Chang, K. C., Shao, S. C., Kuo, S., Yang, C. Y., Chen, H. Y., Chan, Y. Y. & Ou, H. T., 2020 10月 9, 於: Cardiovascular Diabetology. 19, 1, 172.

研究成果: Article › 同行評審

開啟存取

12 引文斯高帕斯（Scopus）

Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes

Yang, C. Y., Su, P. F., Hung, J. Y., Ou, H. T. & Kuo, S., 2020 7月 6, 於: Cardiovascular Diabetology. 19, 1, 105.

研究成果: Article › 同行評審

開啟存取

39 引文斯高帕斯（Scopus）

Cost-effectiveness of long-acting insulin analogues vs intermediate/long-acting human insulin for type 1 diabetes: A population-based cohort followed over 10 years

Lee, T. Y., Kuo, S., Yang, C. Y. & Ou, H. T., 2020 5月 1, 於: British Journal of Clinical Pharmacology. 86, 5, p. 852-860 9 p.

研究成果: Article › 同行評審

開啟存取

15 引文斯高帕斯（Scopus）

Cost-utility analysis of inotuzumab ozogamicin for relapsed or refractory B cell acute lymphoblastic leukemia from the perspective of Taiwan’s health care system

Lee, T. Y., Chen, H. Y., Chen, T. Y., Li, S. S., Fang, W. T., Wen, Y. C., Lo, Y. W. & Ou, H. T., 2020 9月 1, 於: European Journal of Health Economics. 21, 7, p. 1105-1116 12 p.

研究成果: Article › 同行評審

4 引文斯高帕斯（Scopus）

Early scale-up of antiretroviral therapy at diagnosis for reducing economic burden of cardiometabolic disease in HIV-infected population

Yang, C. T., Toh, H. S., Liao, C. T., Kuo, S., Ou, H. T. & Ko, N. Y., 2020 5月 1, 於: AIDS. 34, 6, p. 903-911 9 p.

研究成果: Article › 同行評審

開啟存取

3 引文斯高帕斯（Scopus）

歐 凰姿

研究成果

搜尋結果

歐凰姿